Manchester, the midland hotel, UK, The 5th Annual Biomarkers Congress. MicroBioChips is the sponsor of this event dedicated for the most senior level biomarkers practitioners from the world’s leading pharmaceutical and biotechnology companies..

MicroBiochips is the French biotechnology company dedicated to protein&antibody biochips services and products. The company decides to sponsor the 5th Annual Biomarkers Congress , Manchester, the midland hotel, UK.
The primary objective of this event is to explore core topics such as the return on investment of Biomarkers, the key role of personalised medicine and diagnostics, safety biomarkers and biomarkers within clinical development, biomarker discovery & validation in different therapeutic areas as well as the integration of applications and enabling technologies such as imaging, metabolomics and microRNA to maximise biomarker identification.
The summit's programme topics have been pinpointed and validated by some of the most prominent practitioners within biomarker discovery scientific community as the top critical issues they face.

Biomarkers promises to transform drug discovery, clinical development and molecular diagnostics in the R&D process as effective use of biomarkers at each stage of R&D can improve decision-making, increase clinical trial success rates and productivity.

MicrobioChips intends to introducing its innovative technology microarray platform to provide high value services and products to scientific communities involved in biomarker discovery. Our expertise and know-how in protein microarray management will have an effect on minimising bottlenecks and getting candidates to the pre-clinical and evolution stages cheaper and faster.